Sukhbir Kaur

9PUBLICATIONS
5CO-AUTHORS
Innate immunityTissue engineeringTumour immunologyInfant and child healthMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 13, 2026
Dual TLR7/8 Activation by Dihydroxyimidazoquinoline Adjuvant Orchestrates NF-κβ-iNOS-Driven Th1 Immunity and Durable Protection Against Leishmania donovani.

Shivani Thakur, Sandeep Kaur, Kushvinder Kumar

|Feb 16, 2026
Novel Imidazoquinoline Based TLR7 Agonist Induces Antileishmanial Efficacy-An In Vitro Study.

Shivani Thakur, Kushvinder Kumar, Sandeep Kaur

|Oct 20, 2025
Dual immunomodulatory and antileishmanial potential of TLR7/8 agonists against Leishmania donovani.

Shivani Thakur, Deepender Kaushik, Kushvinder Kumar

|Jun 03, 2025
A comprehensive review of cerebral malaria.

Pooja Beniwal, Jyoti Joshi, Sukhbir Kaur

|Feb 28, 2025
Gefitinib as an antimalarial: unveiling its therapeutic potential.

Varun Gorki, Neha Sylvia Walter, Monika Chauhan

|Nov 18, 2022
In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model.

Poonam Keshav, Deepak Kumar Goyal, Sukhbir Kaur

Pageof 2

Frequent Collaborators

2 joint publications

Deepak B Salunke

1 joint publications

Anil B Jindal

1 joint publications

Shivani Thakur

1 joint publications

Kushvinder Kumar